These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 34605778

  • 1. Association Between Vasopressin Rebranding and Utilization in Patients With Septic Shock.
    Sacha GL, Kiser TH, Wright GC, Vandivier RW, Moss M, Burnham EL, Ho PM, Reynolds PM, Bauer SR.
    Crit Care Med; 2022 Apr 01; 50(4):644-654. PubMed ID: 34605778
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Epidemiology of Vasopressin Use for Adults with Septic Shock.
    Vail EA, Gershengorn HB, Hua M, Walkey AJ, Wunsch H.
    Ann Am Thorac Soc; 2016 Oct 01; 13(10):1760-1767. PubMed ID: 27404213
    [Abstract] [Full Text] [Related]

  • 4. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
    Sacha GL, Lam SW, Wang L, Duggal A, Reddy AJ, Bauer SR.
    Crit Care Med; 2022 Apr 01; 50(4):614-623. PubMed ID: 34582425
    [Abstract] [Full Text] [Related]

  • 5. Optimizing Vasopressin Use and Initiation Timing in Septic Shock: A Narrative Review.
    Sacha GL, Bauer SR.
    Chest; 2023 Nov 01; 164(5):1216-1227. PubMed ID: 37479058
    [Abstract] [Full Text] [Related]

  • 6. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database.
    He D, Zhang L, Hu H, Gu WJ, Lu X, Qiu M, Li C, Yin H, Lyu J.
    Am J Emerg Med; 2023 Jul 01; 69():188-194. PubMed ID: 37167890
    [Abstract] [Full Text] [Related]

  • 7. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
    Menich BE, Miano TA, Patel GP, Hammond DA.
    Ann Pharmacother; 2019 Sep 01; 53(9):877-885. PubMed ID: 30957512
    [Abstract] [Full Text] [Related]

  • 8. Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study.
    Kulesza S, Gignac L, Colvin CA, Boll S, Giuliano C, Haan B, Allen B, Perez MM, Allen M, Edwin SB.
    Pharmacotherapy; 2023 Aug 01; 43(8):787-794. PubMed ID: 37148191
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
    Russell JA, Lee T, Singer J, Boyd JH, Walley KR, Vasopressin and Septic Shock Trial (VASST) Group.
    Crit Care Med; 2017 Jun 01; 45(6):940-948. PubMed ID: 28333757
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.
    Erwin BL, Denaburg MA, Barker AB, McArdle PJ, Windham ST, Morgan CJ.
    Crit Care Med; 2017 Dec 01; 45(12):e1226-e1232. PubMed ID: 28991825
    [Abstract] [Full Text] [Related]

  • 12. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST, Shah P, Hollands JM, Shah RA, Shannon WD, Kollef MH.
    Surg Infect (Larchmt); 2007 Apr 01; 8(2):189-200. PubMed ID: 17437364
    [Abstract] [Full Text] [Related]

  • 13. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD.
    Pharmacotherapy; 2004 Aug 01; 24(8):1002-12. PubMed ID: 15338849
    [Abstract] [Full Text] [Related]

  • 14. Machine learning to predict vasopressin responsiveness in patients with septic shock.
    Scheibner A, Betthauser KD, Bewley AF, Juang P, Lizza B, Micek S, Lyons PG.
    Pharmacotherapy; 2022 Jun 01; 42(6):460-471. PubMed ID: 35426141
    [Abstract] [Full Text] [Related]

  • 15. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
    Xu J, Cai H, Zheng X.
    BMC Infect Dis; 2023 Apr 03; 23(1):199. PubMed ID: 37013474
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
    Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ, VANISH Investigators.
    JAMA; 2016 Aug 02; 316(5):509-18. PubMed ID: 27483065
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. After the Rebranding and Cost Increase, the Use of Vasopressin Continues to Increase Yearly Especially in Case of Acute Kidney Injury With Septic Shock: Is There Recent Data Justifying It?
    Honore PM, Redant S, Djimafo P, Blackman S, Bousbiat I, Perriens E, Preseau T, Cismas BV, Kaefer K, Gutierrez LB, Anane S, Gallerani A, Attou R.
    Crit Care Med; 2023 Feb 01; 51(2):e68-e69. PubMed ID: 36661471
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.